Ausgewählte Publikationen

Roeder, R. G. Unique Immune Cell Coactivators Specify Locus Control Region Function and Cell Stage. Mol Cell 80, 845-861.e10 (2020).

Duy, C., Teater, M., Garrett-Bakelman, F. E., Lee, T. C., Meydan, C., Glass, J. L., Li, M., Hellmuth, J. C., Mohammad, H. P., Smitheman, K. N., Shih, A. H., Abdel-Wahab, O., Tallman, M. S., Guzman, M. L., Muench, D., Grimes, H. L., Roboz, G. J., Kruger, R. G., Creasy, C. L., Paietta, E. M., Levine, R. L., Carroll, M. & Melnick, A. M. Rational Targeting of Cooperating Layers of the Epigenome Yields Enhanced Therapeutic Efficacy against AML. Cancer Discovery 9, 872–889 (2019).

Doane, A. S., Chu, C.-S., Di Giammartino, D. C., Rivas, M. A., Hellmuth, J. C., Jiang, Y., Yusufova, N., Alonso, A., Roeder, R. G., Apostolou, E., Melnick, A. M. & Elemento, O. OCT2 pre-positioning facilitates cell fate transition and chromatin architecture changes in humoral immunity. Nat Immunol 22, 1327–1340 (2021).

Hellmuth, J. C.*, Louissaint, A.*, Szczepanowski, M., Haebe, S., Pastore, A., Alig, S., Staiger, A. M., Hartmann, S., Kridel, R., Ducar, M. D., Koch, P., Dreyling, M., Hansmann, M.-L., Ott, G., Rosenwald, A., Gascoyne, R. D., Weinstock, D. M., Hiddemann, W., Klapper, W. & Weigert, O. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles. Blood 132, 1695–1702 (2018).